The Netherlands Cancer Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

The Netherlands Cancer Institute
Jun 29, 2025, 07:14 | Blog
Winan van Houdt Highlights New Article on Surgical Strategies for TIL Therapy in Melanoma
Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek, shared a post by Marco Donia, Research…
Jan 22, 2025, 16:42 | Career
Myriam Chalabi: Position available for a PhD student in computational biology/bioinformatics
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher in Gastrointestinal Oncology at Antoni van Leeuwenhoek…
Dec 2, 2024, 15:28 | Insight
Gabe Sonke: Grateful to all patients who participated in the SONIA trial
Gabe Sonke, Professor of Clinical Oncology at the Netherlands Cancer Institute, shared a post by…
Nov 30, 2024, 14:02 | Insight
First Results of the Dutch SONIA Trial on CDK4/6 Inhibitors
Evaluating the Impact of CDK4/6 Inhibitors in First- and Second-Line Endocrine Therapy for HR+, HER2-…
Nov 14, 2024, 15:54 | Insight
Applications for the NKI PhD program are open
The Netherlands Cancer Institute share a post on X: “Applications for the NKI PhD program…
Nov 6, 2024, 13:24 | Blog
Ton Schumacher was bestowed the 2024 ESMO Award for Immuno-Oncology
The ESMO Award for Immuno-Oncology 2024 was presented to Ton N. Schumacher in recognition of…
Oct 26, 2024, 11:02 | Blog
Winan van Houdt: The vital role of the surgeon in TIL treatment for metastatic melanoma
Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek, shared a post on LinkedIn: "Discussing…
Oct 17, 2024, 16:13 | Blog
The Netherlands Cancer Institute is looking for a junior group leader
The Netherlands Cancer Institute shared a post on X: "We're looking for a junior group leader!…
Oct 11, 2024, 18:12 | Blog
Keep Research Curious Free Public Webinar - EACR
European Association for Cancer Research - EACR shared on LinkedIn: "As part of our Keep…
Sep 27, 2024, 16:31 | Insight
Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute
The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…
Sep 18, 2024, 11:49 | Blog
Myriam Chalabi: Young talent Manon de Graaf presenting data on patients with stage 1 TNBC
Myriam Chalabi shared a post on X: ''Young talent Manon de Graaf from The Netherlands…
Sep 15, 2024, 16:26 | Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 12, 2024, 10:29 | Career
John Haanen Honored with 2024 ESMO Lifetime Achievement Award
John Haanen was recently awarded the 2024 ESMO Lifetime Achievement Award. John B.A.G. Haanen is…
Sep 1, 2024, 10:46 | Insight
Article of the day, September 1st, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 11, 2024, 11:59 | Blog
Myriam Chalabi: Management of Locally Advanced Rectal Cancer, ASCO Guidelines
Myriam Chalabi, Medical Oncologist at The Netherlands Cancer Institute, shared a post on X about…
Aug 4, 2024, 04:14 | Positive
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
As we reflect on July's Sarcoma Awareness Month, we are honored to spotlight the incredible…
Aug 1, 2024, 03:50 | Insight
Daniel Peeper: Rational combination of cancer therapies with PD1 axis blockade
Daniel Peeper, Cancer Researcher at The Netherlands Cancer Institute, shared a post on X: “Happy…
Jul 11, 2024, 17:37 | Blog
Myriam Chalabi: An important international study on whether high TILs can be used to safely omit chemotherapy in TNBC
Myriam Chalabi shared a post by The Netherlands Cancer Institute, on X, adding: ''Congratulation Marleen Kok…
Jul 10, 2024, 05:38 | Blog
Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X: "Incredibly…
Jul 4, 2024, 14:44 | Insight
Elizabeth McKenna: The July issue of Cancer Discovery is now online
Elizabeth McKenna shared a post on LinkedIn: “The July issue of Cancer Discovery is now online!…
Jun 30, 2024, 16:30 | Insight
Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs
Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn: “Patients with stage…
Jun 15, 2024, 15:32 | Blog
Yüksel Ürün: As a GU oncologist my non-GU key highlights from ASCO24
Yüksel Ürün shared on X/Twitter: "As a GU oncologist my non-GU key highlights from ASCO24. 1.…
Jun 12, 2024, 17:27 | Blog
Winette van der Graaf: Two papers in the New England Journal of Medicine in one week
Winette van der Graaf shared a post on their LinkedIn: ''Extremely proud and grateful for…
Jun 8, 2024, 06:59 | Blog
Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute
The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…
Jun 8, 2024, 03:53 | Societies
25 Posts From ASCO24 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jun 7, 2024, 08:23 | Blog
Myriam Chalabi: The results of the NICHE-2 study now published in NEJM
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 6, 2024, 02:56 | Blog
Results from the Phase 3 NADINA Clinical Trial - Melanoma Institute Australia
Melanoma Institute Australia posted on LinkedIn: "Heralded as a cancer treatment revolution, the pre-surgery (neoadjuvant)…
May 17, 2024, 11:25 | Insight
Stefan Michiels: Discussing important clinical trial design challenges in breast cancer!
Stefan Michiels, Head Oncostat Team at INSERM, shared a post by Marleen Kok, Associate Professor…
Apr 29, 2024, 22:33 | Blog
Marleen Kok: Institutional visit by Ulrike Harjes, Senior Editor of Nature Medicine, to The Netherlands Cancer Institute
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X/Twitter: ''Institutional…
Apr 29, 2024, 11:49 | Blog
Winan van Houd: How collaboration can lead to better understanding of rare cancers
Winan van Houd shared a post on LinkedIn: "We started the PhD journey of Eva Huis…
Apr 25, 2024, 12:10 | Blog
Myriam Chalabi: Very happy to host Ulrike Harjes from Nature Medicine
Myriam Chalabi: Medical Oncologist and Cancer Immunotherapy Researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Apr 22, 2024, 16:05 | Blog
Steffen Fuchs: The abstract submission is open for the 2nd Young Scientist Cancer Congress
Steffen Fuchs, Postdoctoral Researcher at Cancer Research Center of Toulouse, shared a post on LinkedIn:…
Apr 14, 2024, 03:20 | Insight
Emile Voest: A comprehensive catalogue of microbia present in metastatic cancers
Emile Voest, Professor of Medical Oncology at The Netherlands Cancer Institute, shared a post by…
Apr 13, 2024, 08:20 | Blog
Joris van de Haar: We characterize the microbial DNA in metastatic cancers with unprecedented accuracy, breath and depth
Joris van de Haar, Translational Research and Precision Medicine Working Group at ESMO, shared a post…
Mar 18, 2024, 10:14 | Blog
Winette van der Graaf: Netherlands in ESMO Sarcoma Rare Cancers Meeting
Winette van der Graaf, Head of Department of Medical Oncology at The Netherlands Cancer Institute,…
Feb 24, 2024, 16:50 | Blog
Toni Choueiri: New insights from the JAVELIN Renal 101 trial in RCC in Cancer Discovery
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center for…
Jan 22, 2024, 17:43 | Blog
Marleen Kok: Such a joy to see you shine
Marleen Kok, Associate Professor at The Netherlands Cancer Institute shared a post by Olga Blomberg,…
All: 37 Posts: 1 - 100
Special Coverage